Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent PathwayVicki Thallas‐Bonke, Josephine M. Forbes, Felicia Y. T. Yap et al.|Diabetes|2007Cited by 346
SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital AdmissionPeter S. Hamblin, Leon A. Bach, Rosemary Wong et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 122